Lauren Merendino, Chief Commercial Officer at Day One Biopharmaceuticals, Inc. (DAWN), sold 3,766 shares at $6.77 ($25K) on 2025-08-18, disclosed to the SEC on 2025-08-19.
Open-market sale of $25k DAWN by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DAWN | SELL | 2025-05-19 | $25K | — | Filing → |
| MYOV | SELL | 2023-01-20 | $108K | — | Filing → |
| MYOV | SELL | 2022-10-20 | $43K | — | Filing → |